Improved diagnostics targeting c-MET in non-small cell lung cancer: expression, amplification and activation?

被引：0

作者：

I. Watermann

B. Schmitt

F. Stellmacher

J. Müller

R. Gaber

Ch. Kugler

N. Reinmuth

R. M. Huber

M. Thomas

P. Zabel

K. F. Rabe

D. Jonigk

A. Warth

E. Vollmer

M. Reck

T. Goldmann

机构：

[1] Clinical and Experimental Pathology,

[2] Research Center Borstel,undefined

[3] LungenClinic Grosshansdorf,undefined

[4] Airway Research Center North (ARCN),undefined

[5] Member of the German Center for Lung Research (DZL),undefined

[6] Ludwig Maximilians University (LMU),undefined

[7] Comprehensive Pneumology Center Munich,undefined

[8] (CPC-M),undefined

[9] Member of the German Center for Lung Research,undefined

[10] Thoracic Oncology Centre Munich,undefined

[11] Medical Clinic,undefined

[12] Research Center Borstel,undefined

[13] Institute of Pathology,undefined

[14] Hannover Medical School,undefined

[15] Biomedical Research in Endstage and Obstructive Lung Disease Hanover (BREATH),undefined

[16] Member of the German Center for Lung Research,undefined

[17] Institute of Pathology,undefined

[18] Heidelberg University,undefined

[19] Translational Lung Research Center (TLRC),undefined

[20] Member of the German Center for Lung Research,undefined

[21] Pathology,undefined

[22] Faculty of Medicine,undefined

[23] Alexandria University,undefined

来源：

Diagnostic Pathology | / 10卷

关键词：

Non-small cell lung Cancer (NSCLC); MET; Targeted therapies; Diagnostic; Phosphorylated MET; Immunohistochemistry; Fluorescence in situ hybridization;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[41] Correlation among genetic variations of c-MET in Chinese patients with non-small cell lung cancer
Duan, Jianchun
Yang, Xiaodan
Zhao, Jun
Zhuo, Minglei
Wang, Zhijie
An, Tongtong
Bai, Hua
Wang, Jie
ONCOTARGET, 2018, 9 (02) : 2660 - 2667
[42] The HGF/c-Met pathway activates COX-2 in non-small cell lung cancer
Siegfried, Jill M.
Gubish, Christopher T.
de Oliveira, Pierre E. Queiroz
Stabile, Laura P.
CANCER RESEARCH, 2006, 66 (08)
[43] Expression profiles of EGFR, c-Met, and mTOR/Wnt alternative signaling pathway proteins in non-small cell lung cancer
Shearrow, Caleb
Crees, Zachary
Girard, Jennifer
Harrington, Kymberly
Arasi, Kavin
Bertram, Ceyda
Nowak, Andrew
Lin, Leo
Sheu, Bonnie
Palani, Sunil
Puri, Neelu
CANCER RESEARCH, 2015, 75
[44] c-Met expression and response to telisotuzumab vedotin (teliso-v) in patients with non-small cell lung cancer.
Heist, Rebecca Suk
Motwani, Monica
Barlesi, Fabrice
Goldman, Jonathan Wade
Kelly, Karen
Sun, Yan
Wu, Jun
Bach, Bruce Allen
Camidge, D. Ross
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[45] Meeting an un-MET need: Targeting MET in non-small cell lung cancer
Michaels, Elena
Bestvina, Christine M.
FRONTIERS IN ONCOLOGY, 2022, 12
[46] Aggregation of lipid rafts activates c-met and c-Src in non-small cell lung cancer cells
Juan Zeng
Heying Zhang
Yonggang Tan
Cheng Sun
Yusi Liang
Jinyang Yu
Huawei Zou
BMC Cancer, 18
[47] Aggregation of lipid rafts activates c-met and c-Src in non-small cell lung cancer cells
Zeng, Juan
Zhang, Heying
Tan, Yonggang
Sun, Cheng
Liang, Yusi
Yu, Jinyang
Zou, Huawei
BMC CANCER, 2018, 18
[48] Nicotinamide phosphoribosyltransferase (Nampt) regulates growth of non-small cell lung cancer cells with c-Met overexpression
Okumura, Shunsuke
Minami, Yoshinori
Endoh, Satoshi
Sasaki, Takaaki
Satoh, Kazuhiro
Kitada, Masahiro
Ohsaki, Yoshinobu
CANCER RESEARCH, 2011, 71
[49] The Efficacy and Risk Profile of c-Met inhibitors in Non-small Cell Lung Cancer: a Meta-analysis
Sa Ye
Jiuke Li
Ke Hao
Jianping Yan
Hongbin Zhou
Scientific Reports, 6
[50] Chidamide increases the sensitivity of Non-small Cell Lung Cancer to Crizotinib by decreasing c-MET mRNA methylation
Ding, Nan
You, Abin
Tian, Wei
Gu, Liankun
Deng, Dajun
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2020, 16 (14): : 2595 - 2611

← 1 2 3 4 5 →